DavidLevy's blog

Next-Generation Sequencing (NGS) Services Market Focuses on Market Share, Size and Projected Forecast Till 2031

DavidLevy's photo
DavidLevy
·

5 min read

The "Next-Generation Sequencing (NGS) Services Market" is focused on controlling cost, and improving efficiency. Moreover, the reports offer both the demand and supply aspects of the market. The Next-Generation Sequencing (NGS) Services market is expected to grow annually by 7.8% (CAGR 2024 - 2031).

This entire report is of 119 pages.

Next-Generation Sequencing (NGS) Services Introduction and its Market Analysis

Next-Generation Sequencing (NGS) Services market research reports indicate a promising market outlook driven by factors such as technological advancements, increasing demand for precision medicine, and growing applications in fields like oncology, infectious diseases, and agriculture. Major players in the NGS services market include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, Novogene, Genotypic Technology, and Dna Link. The report highlights the competitive landscape, market trends, and future opportunities for growth in the NGS services market. Recommendations focus on strategic partnerships, product innovation, and expansion into emerging markets.

Get a Sample PDF of the Report: https://www.reliableresearchreports.com/enquiry/request-sample/1319459

Next-Generation Sequencing (NGS) Services market is witnessing rapid growth, driven by increased demand for personalized medicine. Targeted Sequencing, Whole Exome Sequencing, and Whole Genome Sequencing are some of the key services in this market. Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations, and Others are the major end-users of NGS services.

Regulatory and legal factors specific to the NGS market include the need for compliance with data protection laws, quality control measures, and ethical considerations in handling genetic data. Additionally, ensuring accurate and reliable results, protecting patient confidentiality, and adhering to industry standards are critical aspects for NGS service providers to consider in order to maintain market competitiveness and gain trust from customers. Overall, the NGS services market is poised for continued growth as advancements in technology and regulatory frameworks continue to shape the industry landscape.

Top Featured Companies Dominating the Global Next-Generation Sequencing (NGS) Services Market

The Next-Generation Sequencing (NGS) Services Market is highly competitive with key players such as Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, Novogene, Genotypic Technology, and Dna Link vying for market share. These companies offer a wide range of NGS services including whole genome sequencing, RNA sequencing, targeted sequencing, and metagenomic sequencing among others.

Eurofins Scientific is a major player in the NGS services market offering high-quality sequencing solutions to meet the needs of various industries such as pharmaceuticals, biotechnology, healthcare, and agriculture. Natera specializes in non-invasive prenatal testing and cancer screening using NGS technology. BGI is known for its vast sequencing capacity and ability to handle large-scale projects.

Illumina, Roche, and LabCorp are well-established companies that provide a range of NGS services and have significant market presence. Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, Novogene, Genotypic Technology, and Dna Link are also key players in the NGS services market offering innovative solutions to cater to the growing demand for genomic sequencing.

These companies use NGS services to help advance research in areas such as personalized medicine, agricultural genomics, and microbiome studies. Their expertise and technological advancements contribute to the growth of the NGS services market by providing researchers and clinicians with advanced sequencing solutions.

In terms of sales revenue, Illumina reported approximately $ billion in revenue in 2020, while Roche reported around $64 billion in revenue in the same year. LabCorp, a leading healthcare diagnostics company, reported revenue of approximately $14 billion in 2020. These figures highlight the significant market presence and growth potential of these companies in the NGS services market.

  • Eurofins Scientific
  • Natera
  • BGI
  • Illumina
  • Roche
  • LabCorp
  • Berry Genomics
  • Brooks Life Sciences
  • Macrogen
  • Personalis
  • Novogene
  • Genotypic Technology
  • Dna Link

Get a Sample PDF of the Report: https://www.reliableresearchreports.com/enquiry/request-sample/1319459

Next-Generation Sequencing (NGS) Services Market Analysis, by Type:

  • Targeted Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing

Targeted sequencing focuses on specific regions of the genome, providing cost-effective and efficient analysis of specific genes of interest. Whole exome sequencing captures all exons in the genome, enabling comprehensive assessment of protein-coding regions. Whole genome sequencing examines the entire genome, offering a complete view of an individual's genetic makeup. These services cater to diverse research and clinical applications, driving demand for NGS services. The ability to identify genetic variants associated with diseases, personalize healthcare, and advance precision medicine has significantly increased the demand for NGS services in various fields, including healthcare, agriculture, and forensics.

Inquire or Share Your Questions If Any Before the Purchasing This Report -https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1319459

Next-Generation Sequencing (NGS) Services Market Analysis, by Application:

  • Hospitals and Clinics
  • Biopharma Companies
  • Academic & Research Organizations
  • Others

Next-Generation Sequencing (NGS) Services are used in hospitals and clinics for diagnostics, monitoring treatment response, and personalized medicine. Biopharma companies utilize NGS for drug development, biomarker discovery, and clinical trials. Academic & research organizations use NGS for genomic studies, population genetics, and disease research. Other applications include agriculture, forensic science, and environmental monitoring.

The fastest growing application segment in terms of revenue is biopharma companies, as they increasingly rely on NGS for precision medicine and targeted therapies. NGS services provide high-throughput sequencing, accurate results, and cost-effectiveness, making them indispensable tools in various fields.

Purchase this Report (Price 3660 USD for a Single-User License): reliableresearchreports.com/purchase/1319459

Next-Generation Sequencing (NGS) Services Industry Growth Analysis, by Geography:

North America:

  • United States
  • Canada

Europe:

  • Germany
  • France
  • U.K.
  • Italy
  • Russia

Asia-Pacific:

  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia

Latin America:

  • Mexico
  • Brazil
  • Argentina Korea
  • Colombia

Middle East & Africa:

  • Turkey
  • Saudi
  • Arabia
  • UAE
  • Korea

The Next-Generation Sequencing (NGS) Services market is expected to experience significant growth across regions including North America (United States, Canada), Europe (Germany, France, ., Italy, Russia), Asia-Pacific (China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia), Latin America (Mexico, Brazil, Argentina, Colombia), and Middle East & Africa (Turkey, Saudi Arabia, UAE). North America and Europe are expected to dominate the market, with a combined market share of over 50%. Asia-Pacific is also expected to witness substantial growth, with an expected market share of around 20%. Latin America and Middle East & Africa are projected to have smaller but still significant market shares.

Purchase this Report (Price 3660 USD for a Single-User License): reliableresearchreports.com/purchase/1319459

Check more reports on reliableresearchreports.com